This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
the additional pregnancies, births, and abortions due to the loss of confidentiality; the rates of female prevalence of chlamydia, gonorrhoea; the proportion of pelvic inflammatory disease (PID) resulting from untreated chlamydia or untreated gonorrhoea; the proportion of patients returning for treatment; treatment effectiveness for chlamydia and gonorrhoea; additional untreated chlamydia and gonorrhoea cases, and additional PID due to untreated chlamydia and gonorrhoea cases, arising from the loss of confidentiality; and the population of eligible girls in Texas in 2001.
Study designs and other criteria for inclusion in the review
It was unclear whether a systematic review of the literature had been undertaken to identify primary studies. The clinical evidence came from multiple sources, and little information on the design and characteristics of the primary studies was provided. Some data were corroborated using personal communications or population census.
Sources searched to identify primary studies
Not stated.
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
The effectiveness evidence came from 15 studies.
Methods of combining primary studies
The authors usually chose conservative estimates among those available from the literature.
Investigation of differences between primary studies
Results of the review
The reduction in clients due to the loss of confidentiality was 37%.
The numbers of pregnancies, births and abortions avoided (per person) among young women receiving reproductive health care per client were 0.3094 (pregnancies), 0.2011 (births) and 0.0619 (abortions), respectively.
The additional pregnancies, births and abortions due to the loss of confidentiality per 100 girls were 11.45 (pregnancies), 7.44 (births) and 2.29 (abortions), respectively.
The rates of female prevalence of chlamydia and gonorrhoea were 10.4% and 2.3%, respectively. The proportions of PID resulting from untreated chlamydia or untreated gonorrhoea were 20% and 10%, respectively.
The proportion of patients returning for treatment was 85%.
The treatment effectiveness was 95% for chlamydia and 99.8% for gonorrhoea.
The numbers of additional untreated chlamydia and gonorrhoea cases per 100 clients were 3.11 and 0.72, respectively.
The number of additional PID per 100 girls due to untreated chlamydia and gonorrhoea cases arising from the loss of confidentiality was 0.69.
The population of eligible girls in Texas in 2001 comprised 72,199 adolescents.
Measure of benefits used in the economic analysis
The model produced the numbers of additional pregnancies, additional births, additional abortions, and additional cases of chlamydia, gonorrhoea and PID associated with the implementation of the new law that limited adolescents' ability to obtain confidential reproductive health care services. However, none of these outputs was used as the summary benefit measure in the economic analysis. In effect, a cost-consequences analysis was performed.
Direct costs
Discounting was not relevant since the costs were incurred during one year. The unit costs were not presented separately from the quantities of resources used as the costs were expressed using macro-categories. The economic evaluation included the costs of a birth (prenatal care, delivery and first-year infant care), abortion, screening and treatment for chlamydia and gonorrhoea (drugs and visits), and lifetime treatment of PID. The cost/resource boundary of the study was unclear since only direct medical costs were included in the analysis. Resource use was estimated from published studies. The costs were derived from Medicaid rates, the Women's Health and Family Planning Association, publicly funded clinics, and published studies. The costs were inflated to 2002 values using the medical care component of the Consumer Price Index.
Statistical analysis of costs
The costs were treated deterministically.
Indirect Costs
The indirect costs were not included.
Currency
US dollars ($).
Sensitivity analysis
Univariate and multivariate sensitivity analyses were carried out to examine the robustness of the base-case results (pregnancy and STI related outcomes and additional costs) to variations in the model inputs. The ranges of values used were, in general, derived from the literature or based on authors' assumptions. Best-and worst-case scenarios were also considered.
Estimated benefits used in the economic analysis
Among the 72,199 girls younger than 18 years of age who were receiving publicly funded reproductive health services in 2001, the loss of confidentiality would lead to 8,265 additional pregnancies, 5,372 additional births, 1.654 additional abortions, 2,243 additional cases of untreated chlamydia infection, 521 cases of untreated gonorrhoea and 501
